Evidence map›Paper›PMID 31470522›Full record

ReviewPathogens (Basel, Switzerland)2019

Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?

Pearl Ihuoma Akazue, Godwin U Ebiloma, Olumide Ajibola, Clement Isaac, Kenechukwu Onyekwelu, Charles O Ezeh, Anthonius Anayochukwu Eze

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Cytological profiling of trypanocidal principles fromPhytomedicine plus : international journal of phytotherapy and phytopharmacology · 2025
    Article
  4. Review
  5. Comprehensive analysis of oral administration of Vitamin E on the early stage ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pearl Ihuoma AkazueDepartment of Biochemistry, Faculty of Life Sciences, University of Benin, Benin City 300283, Nigeria.ORCID 0000-0003-3298-7009
Godwin U EbilomaInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK.ORCID 0000-0003-4072-9800
Olumide AjibolaMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul PO Box 273, The Gambia.
Clement IsaacDepartment of Zoology, Faculty of Life Sciences, Ambrose Alli University, Ekpoma 310101, Nigeria.
Kenechukwu OnyekweluDepartment of Medical Biochemistry, Faculty of Basic Medical Sciences, University of Nigeria, Enugu Campus, Enugu 410001, Nigeria.
Charles O EzehDepartment of Medical Biochemistry, Faculty of Basic Medical Sciences, University of Nigeria, Enugu Campus, Enugu 410001, Nigeria.
Anthonius Anayochukwu EzeDepartment of Medical Biochemistry, Faculty of Basic Medical Sciences, University of Nigeria, Enugu Campus, Enugu 410001, Nigeria. anthonius.eze@unn.edu.ng.ORCID 0000-0002-4821-1689

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent massive reduction in the numbers of fresh Human African Trypanosomiasis (HAT) infection has presented an opportunity for the global elimination of this disease. To prevent a possible resurgence, as was the case after the reduced transmission of the 1960s, surveillance needs to be sustained and the necessary tools for detection and treatment of cases need to be made available at the points of care. In this review, we examine the available resources and make recommendations for improvement to ensure the sustenance of the already achieved gains to keep the trend moving towards elimination.

Indexed as

eliminationHuman African TrypanosomiasisT. b. gambienseT. b. rhodesiense

Identifiers

PMID31470522
PMCPMC6789789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.